AMA Unveils Enhanced Interactive Tool Aimed at Helping Health Care Providers Identify Underserved Patient Care Areas

CHICAGO – The American Medical Association (AMA) today launched an enhanced version of its Health Workforce Mapper to further help physicians and other health care providers improve patient access to care. 

In addition to illustrating the geographic locations of the health care work force in each state, the tool now provides population health data by geographic location. The new “Population Health Explorer” feature offers data on a variety of population health factors, including health care access and quality, health behaviors such as smoking and alcohol use, demographics, and social environment factors.

“Improving patient access to quality care is a core mission of the AMA, and this mapping tool will show physicians and health care professionals precisely where their skills can most benefit populations in need,” said AMA President Andrew W. Gurman, M.D. “Knowing where health care services are needed most can help providers make the best decisions on where to locate or expand their practices to reach patients in greatest need of access to care.”

Specifically, the AMA’s Health Workforce Mapper tool gives physicians and other health care providers information—using reliable AMA data and other data sources—to identify health professional shortage areas, hospital locations, as well as other related workforce trends.

In addition, the tool can help new physicians close the gap in patient access to care by giving residents and medical students access to important information that allows them to see, from state-to-state, where there are shortages in certain medical specialties.

The newly enhanced tool, developed in collaboration with the American Academy of Family Physicians Robert Graham Center and HealthLandscape, is available to the public free of charge via the AMA website. 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.